483 King Pharmaceuticals. Mar 2011

483 King Pharmaceuticals. Mar 2011

Rebecca Dombrowski FDA, Sarah Napier FDA, Sanket Patel FDA$119.00 - Available Now

FDA investigators audited the King Pharmaceuticals. - Rochester, MI, United States facility and issued inspectional observations (via FDA 483) on 16 Mar 2011.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Mar 2011
  • Location: Rochester, United States
  • FEI: 1876582
Add To Cart